




www.MaterialsViews.com Polymer Scaffolds for Small-Diameter Vascular Tissue 
Engineering P
ERBy Haiyun Ma, Jiang Hu, and Peter X. Ma* To better engineer small-diameter blood vessels, a few types of novel scaf-
folds are fabricated from biodegradable poly( L -lactic acid) (PLLA) by means 
of thermally induced phase-separation (TIPS) techniques. By utilizing the 
differences in thermal conductivities of the mold materials and using benzene 
as the solvent scaffolds with oriented gradient microtubular structures in the 
axial or radial direction can be created. The porosity, tubular size, and the 
orientational direction of the microtubules can be controlled by the polymer 
concentration, the TIPS temperature, and by utilizing materials of different 
thermal conductivities. These gradient microtubular structures facilitate cell 
seeding and mass transfer for cell growth and function. Nanofi brous scaf-
folds with an oriented and interconnected microtubular pore network are 
also developed by a one-step TIPS method using a benzene/tetrahydrofuran 
mixture as the solvent without the need for porogen materials. The structural 
features of such scaffolds can be conveniently adjusted by varying the solvent 
ratio, phase-separation temperature, and polymer concentration to mimic the 
nanofi brous features of an extracellular matrix. These scaffolds were fabri-
cated for the tissue engineering of small-diameter blood vessels by utilizing 
their advantageous structural features to facilitate blood-vessel regeneration.  1. Introduction 
 Cardiovascular disease is still the leading cause of mortality 
in the United States, with 1 million lives lost each year and 
healthcare-related costs exceeding 300 billion dollars. [ 1 ] Large-
diameter (inner diameter  > 6 mm) blood vessels have been suc-
cessfully replaced with non-degradable polymeric materials such 
as Dacron (polyethylene terephthalate, PET) and expanded poly-
tetrafl uoroethylene (ePTFE). However, Dacron and PTFE are 
not the ideal solution for replacing blood vessels because they © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, WeinheiAdv. Funct. Mater. 2010, 20, 2833–2841
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Ann Arbor, MI, 48109 (USA) are not natural tissues. For small-diameter 
(inner diameter  < 6 mm) blood vessels 
(SDBV), poor patency because of throm-
bosis and hyperplasia is a major problem 
when Dacron and PTFE are used. Tissue-
engineered living blood vessels could 
potentially serve as a better source of grafts 
for patients. [ 2–4 ] Scaffolds play a pivotal role 
in tissue engineering. [ 5–11 ] Since Shinoka, 
Ma, and colleagues reported the feasibility 
of constructing heart-valve leafl ets and 
blood vessels using synthetic biodegrad-
able polymer scaffolds, [ 12–15 ] there has been 
a lot of very active research on vascular 
tissue engineering. [ 16–31 ] By using synthetic 
biodegradable polymer scaffolding, it has 
been demonstrated that tissue-engineered 
blood-vessel substitutes could achieve 
adequate mechanical strength for arterial 
implantation either directly [ 13 ] or after in-
vitro pre-cultivation. [ 30 ] 
 The structural design of the biodegrad-
able synthetic matrices or scaffolds is a key 
issue in engineering living vascular substi-
r SDBVs. To fabricate the blood-vessel scaf-
rs should be considered: 1) biocompatibility tutes, especially fo
folds, several facto
and biodegradability of the polymers, 2) a high porosity with a 
structure suitable for cell seeding, distribution, function, and 
tissue regeneration, 3) structural similarity to the native extracel-
lular matrix (ECM) – such as the tubular geometry at a macro-
scopic level and the fi brous architecture at the nanometer scale, 
and 4) adequate mechanical properties to support tissue regen-
eration. Although there are many ongoing efforts to develop 
scaffolds for blood-vessel tissue engineering, the scaffolds devel-
oped up to this point have various drawbacks and limitations. 
Yang fabricated scaffolds for SDBV tissue engineering using 
biodegradable polymers. [ 32 ] However, the micropores in these 
scaffolds were randomly oriented and with non-fi brous walls, 
thus, having a low structural similarity to blood vessels. Our lab 
developed the directional thermally induced phase-separation 
(TIPS) technique to fabricate biodegradable polymer scaffolds 
consisting of an oriented array of open microtubules. [ 33 ] Wang 
and colleagues [ 34 ] prepared poly(lactic-co-glycolic acid) (PLGA) 
blood-vessel scaffolds by adopting this method to achieve an 
axially orientated pore structure in the tubular walls. However, 
these scaffolds had solid walls without nanofi brous structure 
and had very low degree of lateral interconnectivity. Vaz [ 35 ] 
developed a bi-layered tubular scaffold composed of a stiff and 










 Figure  2 .  A–D) Scanning electron microscopy (SEM) images of the cross 
section of the microtubules formed under an axial temperature gradient 
at  − 20  ° C for PLLA/benzene solutions with different concentrations (w/v): 
A) 2.5%; B) 5.0%; C) 7.5%; D) 10.0%. E) SEM image of the longitudinal 
section, 7.5%. F) Illustration of the microtubular structure (inset – cross 
section). fi brous inner layer (PLA/PCL) using the electrospinning tech-
nique. A major limitation of such a scaffold was that the pores 
were too small to allow uniform cell seeding and cultivation. 
Our laboratory developed a phase-separation technique to fab-
ricate synthetic nanofi brous matrices [ 36 ] as well as techniques 
to generate interconnected spherical pores within the polymer 
scaffolds. [ 33 , 37,38 ] However, this is the fi rst time that these tech-
niques are used for the fabrication of tubular scaffolds with ori-
ented pores to facilitate blood-vessel tissue engineering. 
 In this work, we aimed to develop novel scaffolds with struc-
tural features on multiple scales to mimic certain key structural 
features of the extracellular matrix (ECM) and with designed 
pores/channels to facilitate cell seeding and three-dimensional 
blood-vessel regeneration. 
 2. Results 
 2.1. Architecture 
 When the temperature of a polymer solution is reduced below 
the freezing point of the solvent, solid-liquid phase separation 
occurs and a porous scaffold can be obtained after removal 
of the solidifi ed solvent. [ 11 ] When a typical mold such as a 
Tefl on vial is used, random pores are generated as previously 
reported. [ 11 ] These randomly arranged pores are not ideal, 
however, for uniform cell seeding, subsequent proliferation, 
and organized blood-vessel regeneration. In the present work, 
the different parts of the molds are made of different mate-
rials (e.g., thermally more conductive steel and less conduc-
tive Tefl on) so that the different thermal conductivities of these 
materials are utilized to regulate the phase-separation process 
( Figure  1 ). When such a mold is cooled, the phase separation of 
the polymer solution inside occurs under a directionally distrib-
uted temperature fi eld because of the different thermal conduc-
tivities of the materials. For example, the steel parts reach lower 
temperatures (such as the freezing point of the solvent) more 
rapidly than the Tefl on parts. Thus, temperature gradients are © 2010 WILEY-VCH Verlag G
 Figure  1 .  View of the molds used for preparing the oriented gradient 
microtubule-structured scaffolds: (left) schematic illustrations of the 
molds; (top right) appearance of the molds with two different materials; 
(bottom right) appearance of produced scaffolds. formed in the mold, leading to directional phase separation 
and the formation of oriented structures. Detailed structural 
features and the physical properties of these structures are dis-
cussed below. 
 2.1.1. Microtubular Gradient Structure 
 Axial oriented structure : When a polymer solution was placed 
in a mold consisting of a steel bottom and Tefl on wall/shaft/top, 
a temperature gradient was formed from bottom to top (from 
low to high) and maintained uniaxially during the thermally 
induced phase-separation process. The characteristic architec-
ture of an array of parallel microtubules was achieved ( Figure  2 ). 
When benzene was used as the solvent of poly( L -lactic acid) 
(PLLA), the cross sections of the microtubules were polygons 
with 3–7 sides. When the polymer concentration was increased 
from 2.5% to 10%, the porosity of the formed scaffolds was 
slightly reduced from 95% to 90%, and the average pore size 
was also decreased from 120–150  μ m to 80–120  μ m. When the 
phase-separation temperature was decreased from  − 20  ° C to 
 − 196  ° C (liquid nitrogen), the pore size was greatly decreased 
from 115-140  μ m to 20-40  μ m (Table  1 ). 
 Radially oriented gradient structure : When the mold was com-
posed of a steel wall and Tefl on bottom/top/shaft or a reversed 
composition (steel shaft/bottom/top and a Tefl on wall), a tem-
perature gradient was formed in the radial direction either from 
the outside (warmer) to the inside (colder) or from the inside 








 Table  1.  Structural and mechanical properties of the solid-walled PLLA scaffolds. 
Polymer Solvent Concentration 
(w/v, [%])
Phase separation 




[g cm  − 3] 




axial radial axial radial
PLLA Benzene 2.5  − 20  0.064 94.9 0–200 — — — —
PLLA Benzene 2.5  − 20  0.063 95.0 0–210 — — — —
PLLA Benzene 2.5  − 20  0.065 94.8 120–150 0.55 0.32 0.22 0.13
PLLA Benzene 5.0  − 20  0.098 92.2 0–150 1.7 4.9 0.16 0.40
PLLA Benzene 5.0 LN  0.096 92.4 10–20 2.1 5.2 0.20 0.45
PLLA Benzene 5.0  − 20  0.097 92.3 0–155 1.8 4.5 0.17 0.43
PLLA Benzene 5.0 LN  0.094 92.5 10–20 2.0 5.0 0.21 0.48
PLLA Benzene 5.0  − 20  0.102 91.9 115–140 3.8 2.0 0.38 0.15
PLLA Benzene 5.0 LN  0.101 92.0 20–40 4.2 2.9 0.43 0.23
PLLA Benzene 7.5  − 20  0.123 90.2 0–120 2.6 6.3 0.27 0.53
PLLA Benzene 7.5  − 20  0.125 90.1 0–120 2.5 5.9 0.24 0.56
PLLA Benzene 7.5  − 20  0.125 90.1 90–130 4.5 2.8 0.44 0.21
PLLA Benzene 10.0  − 20  0.133 89.4 0–100 3.6 8.4 0.37 0.85
PLLA Benzene 10.0  − 20  0.135 89.3 0–100 3.9 8.7 0.40 0.88
PLLA Benzene 10.0  − 20  0.131 89.6 80–120 7.7 4.0 0.68 0.34
 : O/I oriented structure; : I/O oriented structure; : bottom-top oriented structure 
 Figure  3 .  SEM images of cross sections of a vessel scaffold prepared 
under a radial temperature gradient (I/O structure) at  − 20  ° C for PLLA/
benzene solutions with different concentrations (w/v): A) 2.5%; B) 5.0%; 
C) 7.5%; D) 10.0%. gradient pore structures of the PLLA scaffolds were formed 
( Figure  3 – 5 ). They were named O/I (microtube size decreased 
gradually from outside wall to inside wall) and I/O (microtube 
size decreased gradually from inside wall to outside wall) struc-
tures in the following discussion. 
 It was found that the resulting scaffolds had an oriented 
fi shbone-like architecture, which had parallel microtubes with 
thin partitions. Also, the microtube diameters became radi-
ally larger or smaller along the direction of the temperature 
gradient (summarized in Figure  6 ). For instance, the micro-
tube size of the I/O structured gradient scaffold was gradu-
ally reduced from 200  μ m to nearly zero, whereas that of the 
O/I structured scaffold was gradually increased from about 30 
to 200  μ m. The microtube size was reduced with increasing 
polymer concentration (Figure  2 – 5 and Table  1 ). The radial 
temperature-gradient direction did not signifi cantly affect the 
average pore size at the same polymer concentration. The pore 
size formed under the radial temperature gradient was also 
greatly reduced from 200  μ m to 20  μ m when the temperature 
was changed from  − 20  ° C to  − 196  ° C (Figure  3 – 5 and Table  1 ). 
The phase-separation temperature had no obvious effect on the 
porosity (Table  1 ). It is worth noting that there was no obvious 
gradient microtubule structure and no fi shbone-like structure 
at the phase-separation temperature of  − 196  ° C (Figure  5 ). 
 The phase-separation temperature and the direction 
of the temperature gradient both had clear effects on the 
micro-architecture of the PLLA scaffolds. This is related to the 
nature of the solid-liquid phase separation, in other words, 
to the crystallization of the solvent, which controls the pore 
architecture of the formed scaffold. [ 33 ] Different directions 
of the temperature gradient resulted in different crystalliza-









 Figure  4 .  SEM images of cross sections of vessel scaffolds prepared 
under a radial temperature gradient (O/I structure) at  − 20  ° C from PLLA/
benzene solutions with different concentrations (w/v): A) 2.5%; B) 5.0%; 
C) 7.5%; D) 10.0%. crystallization path under the radial temperature gradient as 
compared to under the axial temperature gradient because of 
the thinner walls. Therefore, at extremely low temperatures 
( − 196  ° C) benzene rapidly crystallized and there was likely not 
enough time to form the gradient and branched pore structure. 
 2.1.2. Nanofi brous Interconnected Structure 
 It has been shown in our previous studies that the nanofi brous 
architecture advantageously enhances bone and cartilage tissue © 2010 WILEY-VCH Verlag G






temperature [ ° C]
Density 
[g cm  − 3 ]
PLLA 100/0 7.5  − 20 0.125
PLLA 90/10 7.5  − 20 0.102
PLLA 80/20 2.5  − 20 0.048
PLLA 80/20 5.0  − 20 0.065
PLLA 80/20 7.5  − 20 0.093
PLLA 80/20 10.0  − 20 0.110
PLLA 80/20 5.0  − 80 0.069
PLLA 80/20 5.0 LN 0.068
PLLA 60:40 7.5  − 20 0.091
PLLA 0/100 7.5  − 20 0.094www.MaterialsViews.com
regeneration. [ 37 , 39–43 ] Natural blood vessels are largely composed 
of collagens Type I and III and elastin, which are fi bers of nano-
meter dimensions. Therefore, using scaffolds that mimic nanosized 
fi ber architecture may be advantageous to engineer blood vessels. 
 Although the scaffolds resulting from PLLA/benzene solu-
tions are partly similar to natural blood vessels in structure, 
their solid pore walls are greatly different from blood vessels 
that are composed of nanofi brous proteins. In the following, 
a benzene/tetrahydrofuran (THF) mixture was used as the 
solvent for PLLA in the TIPS procedure to create a nano-
fi brous scaffold with oriented and interconnected microtubules 
(Figure  7 ). When the solvent was THF alone, the scaffold was 
composed of nanofi bers, but contained few micrometer-sized 
pores (Figure  7 J,K). However, when benzene and THF were 
mixed at various ratios, nanofi brous matrices with oriented 
microtubules on the micrometer scale were created. Sim-
ilar to the scaffold made from a PLLA/benzene solution (see 
section 2.1.1), these scaffolds had low densities and high poros-
ities. The density increased and the porosity decreased with 
increasing polymer concentration. For a benzene/THF ratio of 
9:1 (v/v), the diameter of the microtubule ranged from about 
80  μ m to 250  μ m. A partly nanofi brous structure was formed 
in these microtubule walls and the average diameter of the 
nanofi bers was 165  ± 15 nm. When the ratio of benzene/THF 
was 8:2 (v/v) and 6:4 (v/v), a complete nanofi brous structure was 
achieved. The average fi ber diameter of the fi brous matrices did 
not change statistically with the concentration of the polymer 
or the ratio of benzene/THF. The fi ber diameter was similar to 
that obtained for nanofi brous PLLA matrices fabricated using 
THF alone. However, the size of the microtubules was greatly 
reduced with a further increase of the THF percentage in the 
solvent mixture. 
 At the same benzene/THF ratio, the pore size decreased 
with decreasing temperature (Table  2 ) and increasing 
polymer concentration (Figure  8 and Table  2 ), although the 
diameter of the nanofi bers did not change appreciably with the 
temperature (Figure  9 and Table  2 ). It is important to note that 
in the benzene/THF ratio range studied, the microtubules with 
nanofi brous walls were highly interconnected “tunnels” in the 
scaffolds, and the “tunnels” were also oriented in the orthog-
onal directions. Table  2 summarizes the structural properties of 












90.1 120  ± 16 — 4.5 0.44
91.9 107  ± 15 165  ± 15 4.2 0.41
96.2 153  ± 25 158  ± 20 0.5 0.18
94.8 126  ± 18 155  ± 18 2.9 0.30
92.6 80  ± 7 157  ± 21 3.5 0.38
91.3 77  ± 9 160  ± 31 6.4 0.52
94.5 115  ± 20 158  ± 20 3.2 0.33
94.6 52  ± 12 154  ± 23 3.3 0.32
92.8 20  ± 3 143  ± 20 3.0 0.28








 Figure  5 .  SEM images of the axially oriented gradient structure of scaffolds prepared using 
5.0% (w/v) PLLA/benzene solution at  − 196  ° C: A) cross section of tubular pore structure; 
B) cross section, O/I structure; C) cross section, I/O structure.  Compared to the simple solid-liquid phase separation occur-
ring when using a PLLA/benzene solution, there are likely two 
stages of phase separation when using a PLLA/(benzene/THF) 
solution in the scaffold-fabrication process: a solid-liquid phase 
separation followed by a liquid-liquid phase separation. Ben-
zene has a much higher freezing temperature than THF. There-
fore, during the fi rst stage of the solid-liquid phase separation, 
the crystallization of benzene creates micropores. The oriented 
gradient microtubular structure in the axial or radial direction 
(similar to Figure  2 – 5 ) could again be achieved during this step 
by utilizing a proper temperature gradient. After this stage, the 
polymer solution was separated into a solidifi ed benzene phase 
and a polymer-rich PLLA/THF phase, which was partially com-
partmentalized by the benzene crystals. The nanofi brous struc-
ture was formed during the second stage by spinodal liquid–
liquid phase separation and subsequent crystallization of the 
polymer-rich phase. Figure  10 describes the proposed phase-
separation mechanism of PLLA/(benzene/THF) solutions. 
 2.2. Mechanical Properties 
 The mechanical properties, including the compressive mod-
ulus and compressive yield strength, of our scaffolds are shown 
in Tables  1 and  2 . The typical results on the compressive yield 
strength are presented in Figure  11 and  12 . For the scaffolds 
possessing oriented gradient microtubules, the anisotropic © 2010 WILEY-VCH Verlag GmbH & Co. KGaA, WeinhAdv. Funct. Mater. 2010, 20, 2833–2841





























 Figure  6 .  Pore size of the radially oriented gradient microtubular struc-
ture. (PLLA/benzene solutions with PLLA concentration of 5.0%, phase-
separation temperature:  − 20  ° C) architecture led to anisotropic mechanical 
properties. Both the compressive modulus 
and the yield strength of scaffolds with a 
microtubular architecture were signifi cantly 
greater in the longitudinal direction than 
in the transverse direction of the tubular 
structure (Table  1 and Figure  11 ). Both the 
compressive modulus and the compressive 
yield strength increased with polymer con-
centration, as expected (Tables  1 and  2 and 
Figure  11 ). At the same polymer concentra-
 statistical difference in the mechanical prop-tion, there was no
erties between the two types of radially oriented gradient (O/I 
or I/O) scaffolds (Table  1 and Figure  11 ). 
 The compressive modulus and compressive yield strength of 
the nanofi brous scaffolds with interconnected channels were 
both slightly lower than those of the scaffolds with a solid-walled 
oriented gradient structure at the same polymer concentration 
in the oriented direction of the microtubules. At similar polymer 
concentrations, the scaffolds with a solid-walled structure (pre-
pared using benzene) had a larger average pore size and higher 
skeletal density of the pore walls, which may have led to the 
higher compressive modulus and yield strength. The average 
pore size became smaller and smaller as THF was introduced 
and continually increased, resulting in the looser aggregation 
of nanofi bers in the pore walls, which might be associated with 
the lower compressive modulus and yield strength. 
 2.3. Cellular Migration into the Scaffolds in Vivo 
 To investigate cell migration into and distribution within the 
scaffolds of different pore structures in vivo, scaffolds with 
radially oriented and non-oriented pores were subcutaneously 
implanted into mice. After 2 weeks of implantation, haema-
toxylin and eosin (H-E) staining of the cross sections of the 
implants showed that abundant host cells migrated into the 
scaffolds with orientated pores and the fi broblast-like cells 
appeared to be healthy in the microchannels (Figure  13 A). In 
contrast, substantially fewer cells migrated into the scaffolds 
with non-oriented pores (Figure  13 B). Both types of scaffold 
maintained their geometrical shape and structural integrity 
during the 2-week implantation. 
 3. Discussion 
 It is well recognized that scaffolds play a critical role in tissue 
engineering. The three-dimensional pore structure and surface 
morphology of the scaffolds affect the quality of the tissue being 
developed on the scaffold. However, there are limited reports on 
scaffolds for blood-vessel engineering. Blood vessels, like many 
other tissues including nerve, muscle, tendon, ligament, bone 
and teeth, have oriented architectures. 
 In this paper, biodegradable PLLA scaffolds with an oriented 
microtubular structure along different directions were success-
fully created. We have demonstrated how to control the archi-
tectural parameters such as the porosity, tubular diameter, 










 Figure  7 .  SEM images of PLLA scaffolds prepared using PLLA solutions in benzene and THF using the TIPS technique. A-C: 7.5% (w/v) PLLA/
(benzene/THF), benzene/THF (v/v)  = 9:1; D-F: 7.5% (w/v) PLLA/(benzene/THF), benzene/THF (v/v)  = 8:2; G-I: 7.5% (w/v) PLLA/(benzene/THF), 
benzene/THF (v/v)  = 6:4; J-K: 7.5% (wt/v) PLLA/(benzene/THF), benzene/THF (v/v)  = 0:10. The TIPS temperature was  − 20  ° C. processing parameters, such as the polymer concentration and 
temperature gradient. Moreover, by designing the molds using 
different materials for different parts, we created various ori-
ented microtubules and gradient pore structures. For instance, © 2010 WILEY-VCH Verlag G
 Figure  8 .  SEM images of PLLA scaffolds prepared with various polymer 
concentrations using the TIPS technique (benzene/THF  = 8:2, PLLA con-
centration (w/v): A, 2.5%; B: 5.0%; C: 7.5%; D: 10.0%, the TIPS tempera-
ture was  − 20  ° C). a gradient scaffold was created with an oriented structure from 
the outside wall (with larger pores) to the inside wall (with 
smaller pores). The inside layer with smaller pores could be 
advantageous for the seeding and growth of endothelial cells 
(ECs), whereas the outside layer with the bigger pores could 
create a more suitable environment for the growth of smooth 
muscle cells (SMCs) and their matrix synthesis. It is also likely 
that the radially oriented microtubules within a scaffold pro-
vide an easier pathway for cell seeding and uniform distribu-
tion throughout the scaffold. The scaffold implantation study in 
this paper demonstrates that cells easily migrated into radially 
oriented tubular pores achieving a higher cell density and more 
uniform cell distribution throughout the scaffold than in the 
random pores of the control scaffold. The healthy appearance of 
the cells in the radially oriented pores may be related to the 
better mass-transfer conditions than those in the less inter-
connected pores of the control scaffold. The intact vessel-shaped 
geometry also demonstrates the adequate mechanical proper-
ties to support tissue regeneration in the ectopic implantation 
model used in this study. The effects and mechanisms of the 
pore structure and orientation on cell functions such as pro-
liferation, differentiation, and new-tissue development along 
with the degradation of the polymer scaffolds in a blood-vessel 








 Figure  9 .  SEM images vs. the TIPS temperature (benzene/THF  = 8:2, the 
PLLA concentration was 5.0% (wt/v). A:  − 20  ° C; B:  − 80  ° C; C:  − 196  ° C). 
 Figure  10 .  Schematic illustration of the nanofi brous scaffolds with inter-
connected microtubular structure fabricated using the TIPS process in 
PLLA/benzene/THF solutions. 
 Figure  11 .  Compressive yield strength of PLLA scaffolds prepared with 
benzene as the solvent using the TIPS technique. The PLLA concentration 
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Bottom to top Inspired by the nanofi brous architecture of collagen in 
natural ECM, our laboratory previously developed synthetic 
nanofi brous polymer scaffolds with macro-/micropores by 
combining porogen template-leaching and phase-separation 
techniques. [ 6 , 38 , 44 ] In the present work, we developed a tech-
nique to fabricate scaffolds with both interconnected microtu-
bular pores and a nanofi brous pore-wall architecture without 
using any templates (preformed porogen materials). By simply 
controlling the ratio of benzene/THF, the polymer concen-
tration, and the phase-separation temperature, scaffolds with 
different porosity, microtubule size, and nanofi ber density on 
the microtubule walls can be created, allowing for the optimi-
zation of scaffolds for specifi c cells and specifi c tissues. Dif-
ferent from the non-directional spherical pore structure of the 
scaffolds generated by paraffi n or sugar spheres, both oriented 
and interconnected microtubular networks could be achieved © 2010 WILEY-VCH Verlag GmAdv. Funct. Mater. 2010, 20, 2833–2841in the scaffolds using the new methods developed in this 
work. The new fabrication technique is simple, tunable, and 
can also greatly shorten the production time of the scaffolds. 
Moreover, the technique is versatile and likely has a general 
applicability to other polymers as the mold design and the 
solvent type rather than the polymer type play the main roles 
in determining the gradient microtubular and nanofi brous 
architectures. 
 4. Conclusions 
 This paper presents a few types of novel scaffolds fabricated 
from biodegradable polymers by means of a new thermally 
induced phase-separation technique. Tubular biodegradable 
PLLA scaffolds were fabricated for the tissue engineering of 
small-diameter blood vessels by utilizing their nanostructural 






































































 Varying Benzene/THF ratio, PLLA%=5.0%
 Varying PLLA concentration, Benzene/THF=80:20
 Figure  12 .  Compressive yield strength of PLLA scaffolds prepared with 
PLLA solutions in benzene, THF, and a mixture of benzene/THF using 
the TIPS technique. The TIPS temperature was  − 20  ° C. 
 Figure  13 .  After 2 weeks of implantation, H-E staining of the cross sec-
tions of implants showed that abundant host cells migrated into the 
scaffolds with orientated pores and the fi broblast-like cells appeared to 
be healthy in the microchannels (Figure  13 A), substantially fewer cells 
migrated into the scaffolds with non-oriented pores (Figure  13 B). Both 
types of scaffold maintained their original shapes. Scale bar: 200  μ m. facilitate tissue regeneration. We have demonstrated that it is 
possible to control the architectural parameters such as the 
porosity, pore size, and the orientational direction of the micro-
tubular pores by tuning the processing parameters, including 
the polymer concentration and temperature gradient, especially 
utilizing the differences in thermal conductivity of the mold 
materials. The gradient microtubular structure was shown to 
facilitate cell migration and uniform distribution throughout 
the scaffold in vivo. The oriented gradient pores were also 
intended to improve mass transfer conditions for cell growth 
and function. We also developed nanofi brous scaffolds with an 
oriented and interconnected microtubular pore network by a 
one-step TIPS method without the use of template materials. © 2010 WILEY-VCH Verlag GThe structural features of such scaffolds can be conveniently 
adjusted by varying the solvent ratio, phase-separation temper-
ature, and polymer concentration. The fabrication technology 
does not require expensive facilities, is easy to carry out, and 
can shorten the scaffold fabrication time. These fabrication 
technologies are versatile and could be utilized to fabricate 
scaffolds and complex porous materials from different poly-
mers for tissue engineering and various other applications. 
 5. Experimental Section 
 Materials : PLLA with an inherent viscosity of 1.4–1.8 dl g  − 1 was 
purchased from Boehringer Ingelheim (Ingelheim, Germany) and was 
used as received. Benzene, THF, and other reagents were obtained from 
Aldrich Chemical Company (Milwaukee, WI). They were of analytical 
grade and used without further treatment. 
 Vessel Scaffold Fabrication : Three different molds were designed to 
fabricate different blood-vessel scaffolds with orientation and gradient 
pore structures. The molds were composed of top and bottom plates, 
an inner shaft, and an outer cylinder made of the same or different 
materials, as shown in Figure  1 . The usage of different materials (metal 
and Tefl on) was intended to create different temperature gradients for 
the TIPS process. In the present study, molds with an inner-diameter of 
3.00 mm and an outer-diameter of 5.00 mm were used. 
 The PLLA was dissolved in benzene to form a homogeneous solution 
with a concentration in the range of 2.5%–10%. The polymer solution 
was poured into different molds then transferred into a freezer set to a 
chosen temperature to induce phase separation. The phase-separated 
polymer/solvent system was then transferred into a freeze drying vessel 
at  − 5 to  − 10  ° C in an ice/salt bath, and was freeze-dried under vacuum 
(pressure lower than 0.5 mm Hg) for 72 h. The dried scaffolds were then 
kept in a desiccator until characterization or usage. 
 For the preparation of nanofi brous PLLA scaffolds, a mixture of 
benzene and THF with various ratios was used as the solvent. After phase 
separation, the molds containing the polymer solution were immersed 
into cold hexane for 2 days to extract the solvents, changing the hexane 
three times a day. Hexane was then exchanged with cyclohexane. The 
polymer scaffolds were removed from the cyclohexane, and frozen at 
 − 70  ° C for at least 5 h. The frozen scaffolds were lyophilized at  − 10  ° C 
for 72 h and then kept in a desiccator until usage. 
 Structure/Property Characterization : To estimate the density and 
porosity of the PLLA scaffolds, the inner-diameter, outer-diameter, and 
height of each scaffold were measured after freeze-drying to calculate 
the volume of each scaffold. The mass of each scaffold was measured 
with an analytical balance, and the overall density ( D f ) was calculated 
from the volume and the mass. The porosity  ε of each scaffold was 
calculated from the measured overall density  D f of the fi brous matrix 
and the skeletal density  D p using previously described techniques. The 
porosity was defi ned as:
 
g =










+ X cDc   
(2)
 
where  X c is the degree of crystallinity determined by differential scanning 
calorimetry as described elsewhere. [ 36 ] For PLLA,  D a  = 1.248 g mL  − 1 
(density of amorphous polymer) and  D c  = 1.290 g mL  − 1 (density of 100% 
crystalline polymer). 
 The porous morphologies of the scaffolds were examined using 
scanning electron microscopy (SEM) (S-3200N, Hitachi, Japan). To 







www.MaterialsViews.comblade after freeze-drying. All samples were coated with gold using a 
sputter coater (Desk-II, Denton Vacuum Inc., Moorstown NJ) with 
a pressure below 50 mTorr, a current of approximately 40 mA, and a 
coating time of 120 s. The diameters of the pores and the nanofi bers 
were measured from SEM images using Image-pro plus software (Media 
Cybernetics). More than 40 micropores and nanofi bers were chosen to 
calculate an average diameter. To determine the gradient structure of 
the pores, each wall thickness was divided into ten equal parts from the 
inner-wall to the outer-wall or from outer-wall to inner-wall. 
 The compressive mechanical properties of the PLLA scaffolds 
were measured with an MTS Synergie 200 mechanical tester (MTS 
Systems Corporation, Eden Prairie, MN). For compression testing, the 
specimens were homocentric tubes measuring 5 mm in outer-diameter, 
3 mm in inner-diameter, and 3.0 mm in height. The load was applied 
in the direction either parallel or perpendicular to the tubular axis. The 
crosshead speed was 0.5 mm min  − 1 and the compressive modulus was 
defi ned as the initial linear modulus. The yield strength was determined 
from the cross point of the two tangents on the stress-strain curve around 
the yield point. At least 5 specimens were tested for each sample. 
 Subcutaneous Implantation : The animal procedures were performed 
according to the protocol approved by the University of Michigan 
Committee of Use and Care of Laboratory Animals. The tubular scaffolds 
(2 mm in thickness) were implanted into subcutaneous pockets 
of 6–8 weeks old C57BL/6 male mice (Charles River Laboratories, 
Wilmington, MA). Surgery was performed under general inhalation 
anesthesia with isofl uorane. Two midsagittal incisions were made 
on the dorsa and one subcutaneous pocket was created on each side 
of the incisions using blunt dissection. One scaffold was implanted 
subcutaneously into each pocket. Four samples were implanted for 
each group. After placement of implants, the incisions were closed with 
staples. At the end of the 2-week implantation period, the mice were 
euthanized and the implants were harvested. 
 Histological Analysis : Implants were washed in phosphate-buffered 
saline (PBS), fi xed with 3.7% formaldehyde in PBS overnight, dehydrated 
through a graded series of ethanol, embedded in paraffi n, and sectioned 
at a thickness of 5  μ m. The sections were deparaffi nized, rehydrated with 
a graded series of ethanol, and stained with hematoxylin and eosin (H-E). 
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